UFC Middleweight fighter Kevin Casey and light heavyweight Robert Drysdale will face a possible suspension and fine after they failed drug test, according to an announcement by the Ultimate Fighting Championship (UFC).
Drysdale (7-0), who submitted Keith Berish at the TUF 19 Finale on July 6, provided an elevated testosterone-to-epitestosterone ratio of 12-to-1 while Casey (9-3), who won a first-round knockout over Bubba Bush at UFC 175 on July 5, tested positive for Drostanolone, an anabolic steroid. Both results will likely change to no-contests and both UFC stars will have to appear before the Nevada State Athletic Commission at a future hearing.
The 33-year-old Drysdale was denied a license in October to compete in the state of Nevada when he produced an elevated T/E ratio of 19.4-to-1. Drysdale has previously applied for an exemption to use Testosterone replacement therapy (TRT) but his request was denied. Drysdale denied wrongdoing in the matter and attributed his troubles with the commission to a “bureaucratic issue.” Under the UFC banner, the 33-year old Drysdale now has zero wins in four attempts.
A veteran of “The Ultimate Fighter 17,” Casey made his professional octagon debut at the season finale of the show but lost via second-round TKO to Josh Samman. The UFC subsequently released him and Casey went back to the regional circuit and won three straight fights before an offer to return. The American mixed martial artist was a member on The Ultimate Fighter: Team Jones vs. Team Sonnen and won his preliminary bout over Eldon Sproat via rear naked choke.
A decorated Jiu-Jitsu competitor, Drysdale, was scheduled to make his UFC debut this past August at UFC 163 but withdraw after a reported staph infection. He was later about to Cody Donovan at UFC 167 but tested positive for elevated testosterone (he had an elevated testosterone-to-epitestosterone ratio of 19.4:1 -- one of the highest T:E busts in the history of the sport) in a mandated out-of-competition drug test conducted by the Nevada State Athletic Commission (NSAC). The Brazilian Jiu-Jitsu black belt and professional mixed martial artist made a successful MMA debut when he defeated Bastien Huveneers via arm triangle choke. Drysdale signed a multi-fight deal with Legacy Fighting Championship on February 16, 2012.
In a statement, the UFC said both fighters have been temporarily suspended from competition and informed their positive tests violated the UFC Fighter Conduct Policy and Promotional Agreement with Zuffa, LLC. The UFC statement that it was notified by the Nevada State Athletic Commission that UFC middleweight Kevin Casey and light heavyweight Robert Drysdale failed drug tests following their fights at UFC 175 and The Ultimate Fighter Finale, respectively. It was further added that Casey tested positive for Drostanolone and Drysdale was flagged for an elevated testosterone-to-epitestosterone ratio. The statement also highlighted that the UFC has a strict, consistent policy against the use of any illegal and/or performance-enhancing drugs, stimulants or masking agents by our athletes and will support the NSAC's determination pending a formal hearing at a later date.